Click here to view the programme of session 18
H5N1 influenza virus: from avian origin to human risk – what can be done?
Chair: Christine Jansen
11:15 – 11:45 Spotlight on H5N1
Marion Koopmans, Erasmus mc, The Netherlands
11:45 – 12:15 Immune responses after H5N1 vaccination in humans: from adjuvanted vaccines towards next-generation mRNA vaccines
Robbert van der Most, Vaxxcelence
12:15 – 12:30 Transmission studies of avian influenza virus vaccination in laying hens in the Netherlands
Kim Bouwman, WUR
- Parallelsessie 1
Parallel session 18
Date: 02 Apr 2025Time: 11:15 - 12:30 CETH5N1 influenza virus: from avian origin to human risk – what can be done?